Healthcare -
Biotechnology - NASDAQ - US
$ 5.655
-1.82 %
$ 347 M
Market Cap
-3.18
P/E
GLUE - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative GLUE - Monte Rosa Therapeutics, Inc.
32 M
LAST VALUE
42.73%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR